{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:51:42Z","timestamp":1760061102496,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"vor","delay-in-days":569,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jvs.2022.03.874","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T01:49:49Z","timestamp":1649036989000},"page":"513-522.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Increased thrombogenicity is associated with revascularization outcomes in patients with chronic limb-threatening ischemia"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5803-5324","authenticated-orcid":false,"given":"Naoto","family":"Kuyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Kaikita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanobu","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuro","family":"Mitsuse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Fujisue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Hanatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Sueta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Takashio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Tsujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2022.03.874_bib1","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2022.03.874_bib2","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.jacc.2016.11.007","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"69","author":"Gerhard-Herman","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2022.03.874_bib3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/CIRCINTERVENTIONS.112.975318","article-title":"Endovascular treatment for infrainguinal vessels in patients with critical limb ischemia: OLIVE registry, a prospective, multicenter study in Japan with 12-month follow-up","volume":"6","author":"Iida","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2022.03.874_bib4","first-page":"1047","article-title":"Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease","volume":"76","author":"Schmidt","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2022.03.874_bib5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/CIRCULATIONAHA.113.001811","article-title":"Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia","volume":"128","author":"Liistro","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2022.03.874_bib6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.avsg.2016.08.006","article-title":"Real-world performance of paclitaxel drug-eluting bare metal stenting (Zilver PTX) for the treatment of femoropopliteal occlusive disease","volume":"38","author":"Tran","year":"2017","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2022.03.874_bib7","first-page":"266","article-title":"Predictors of target lesion revascularization in patients undergoing lower extremity percutaneous interventions","volume":"21","author":"Shammas","year":"2009","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.jvs.2022.03.874_bib8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jvs.2004.11.041","article-title":"The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: a 10-year experience","volume":"41","author":"Kudo","year":"2005","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2022.03.874_bib9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1024\/0301-1526\/a000510","article-title":"High on-treatment platelet reactivity and outcomes after percutaneous endovascular procedures in patients with peripheral artery disease","volume":"45","author":"Bernlochner","year":"2016","journal-title":"Vasa"},{"key":"10.1016\/j.jvs.2022.03.874_bib10","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00270-018-2028-7","article-title":"Incidence and endovascular treatment of isolated atherosclerotic popliteal artery disease: outcomes from the IPAD multicenter study","volume":"41","author":"Spiliopoulos","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvs.2022.03.874_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jvs.2007.09.018","article-title":"Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia","volume":"47","author":"DeRubertis","year":"2008","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2022.03.874_bib12","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00380-021-01816-z","article-title":"Clinical outcomes after balloon angioplasty with Crosser device for heavily calcified common femoral and popliteal artery disease","volume":"36","author":"Hassan","year":"2021","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jvs.2022.03.874_bib13","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/jth.13256","article-title":"Assessment of platelet-derived thrombogenicity with the total thrombus-formation analysis system in coronary artery disease patients receiving antiplatelet therapy","volume":"14","author":"Arima","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jvs.2022.03.874_bib14","doi-asserted-by":"crossref","first-page":"7399","DOI":"10.1038\/s41598-017-07939-6","article-title":"Direct oral anticoagulants form thrombus different from warfarin in a microchip flow chamber system","volume":"7","author":"Ishii","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jvs.2022.03.874_bib15","doi-asserted-by":"crossref","first-page":"e002744","DOI":"10.1161\/JAHA.115.002744","article-title":"Total thrombus-formation analysis system (T-TAS) can predict periprocedural bleeding events in patients undergoing catheter ablation for atrial fibrillation","volume":"5","author":"Ito","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jvs.2022.03.874_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.thromres.2021.02.004","article-title":"Hemodialysis-related low thrombogenicity measured by total thrombus-formation analysis system in patients undergoing percutaneous coronary intervention","volume":"200","author":"Nakanishi","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.jvs.2022.03.874_bib17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jcin.2019.10.059","article-title":"The IN.PACT DEEP clinical drug-coated balloon trial: 5-year outcomes","volume":"13","author":"Zeller","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2022.03.874_bib18","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1055\/s-0039-1693411","article-title":"Total thrombus-formation analysis system (T-TAS): clinical application of quantitative analysis of thrombus formation in cardiovascular disease","volume":"119","author":"Kaikita","year":"2019","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jvs.2022.03.874_bib19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.5551\/jat.49700","article-title":"Total thrombus-formation analysis system can predict 1-year bleeding events in patients with coronary artery disease","volume":"27","author":"Mitsuse","year":"2020","journal-title":"J\u00a0Atheroscler Thromb"},{"key":"10.1016\/j.jvs.2022.03.874_bib20","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"Conte","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2022.03.874_bib21","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s12928-013-0164-1","article-title":"Clinical outcome after endovascular treatment for isolated common femoral and popliteal artery disease","volume":"28","author":"Soga","year":"2013","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.jvs.2022.03.874_bib22","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3348\/kjr.2016.17.6.874","article-title":"Predictors for better blood-flow restoration of long-segmental below-the-knee chronic total occlusions after endovascular therapy in diabetic patients","volume":"17","author":"Song","year":"2016","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.jvs.2022.03.874_bib23","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1177\/1526602816671740","volume":"23","author":"Katsanos","year":"2016","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2022.03.874_bib24","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.jacc.2018.08.002","article-title":"Pathology of peripheral artery disease in patients with critical limb ischemia","volume":"72","author":"Narula","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2022.03.874_bib25","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Davi","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2022.03.874_bib26","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1161\/CIRCULATIONAHA.117.024469","article-title":"A\u00a0structured review of antithrombotic therapy in peripheral artery disease with a focus on revascularization: a TASC (InterSociety consensus for the management of peripheral artery disease) initiative","volume":"135","author":"Hess","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2022.03.874_bib27","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/ATVBAHA.119.312864","article-title":"Pathologic disparities between peripheral artery disease and coronary artery disease","volume":"40","author":"Narula","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jvs.2022.03.874_bib28","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.thromres.2012.04.007","article-title":"Stent implantation in the superficial femoral artery: short thrombelastometry-derived coagulation times identify patients with late in-stent restenosis","volume":"130","author":"Cvirn","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.jvs.2022.03.874_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.17219\/acem\/38160","article-title":"Tissue factor and other hemostatic parameters in patients with advanced peripheral artery disease after endovascular revascularization\u2014search for hemostatic factors which indicate restenosis","volume":"24","author":"Kotschy","year":"2015","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.jvs.2022.03.874_bib30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-0038-1646173","article-title":"The effects of flow on blood coagulation and thrombosis","volume":"70","author":"Slack","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jvs.2022.03.874_bib31","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2022.03.874_bib32","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2022.03.874_bib33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jacc.2021.04.083","article-title":"Mortality benefit of rivaroxaban plus aspirin in patients with chronic coronary or peripheral artery disease","volume":"78","author":"Eikelboom","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2022.03.874_bib34","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jvs.2006.07.044","article-title":"Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: a randomized controlled trial","volume":"44","author":"Koppensteiner","year":"2006","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2022.03.874_bib35","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.jvir.2011.03.015","article-title":"Batroxobin plus aspirin reduces restenosis after angioplasty for arterial occlusive disease in diabetic patients with lower-limb ischemia","volume":"22","author":"Wang","year":"2011","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvs.2022.03.874_bib36","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jvs.2021.09.040","article-title":"Predictors of outcome in diabetic patients undergoing infrapopliteal endovascular revascularization for chronic limb-threatening ischemia","volume":"75","author":"Yap","year":"2022","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2022.03.874_bib37","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.jcin.2020.06.059","article-title":"Real-world experience with a paclitaxel-coated balloon in critical limb ischemia: 24-month subgroup outcomes of BIOLUX P-III","volume":"13","author":"Brodmann","year":"2020","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521422013684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521422013684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:37:15Z","timestamp":1760042235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521422013684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0741521422013684"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2022.03.874","relation":{},"ISSN":["0741-5214"],"issn-type":[{"type":"print","value":"0741-5214"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased thrombogenicity is associated with revascularization outcomes in patients with chronic limb-threatening ischemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2022.03.874","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the Society for Vascular Surgery. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}